Latest posts 5
Vedanta Biosciences Receives Fast Track Designation for VE303 and Presents Phase 2 Data at Digestive Disease Week
vedantabio.com/news-media/pre…
vedantabio.com/news-media/pre…
Thank you @Nasdaq for giving @VedantaBio the spotlight in Times Square!
Vedanta Biosciences Publishes Phase 2 Results in the Journal of the American Medical Association and Presents at ECCMID
businesswire.com/news/home/2023…
businesswire.com/news/home/2023…